迈普医学股东深圳凯盈、风炎基金拟减持不超1.22%股份
Medprin Regenerative Medical Technologies Medprin Regenerative Medical Technologies (SZ:301033) Zhi Tong Cai Jing·2025-12-12 12:57

Group 1 - The company Maipu Medical (301033.SZ) announced that it received notices from shareholders Shenzhen Kaiying and Fengyan Fund regarding planned share reductions [1] - Shenzhen Kaiying intends to reduce its holdings by no more than 150,000 shares, which represents approximately 0.2237% of the company's total share capital [1] - Fengyan Fund plans to reduce its holdings by no more than 668,100 shares, accounting for about 0.9964% of the current share capital (or 1.0000% when excluding the company's repurchase account) [1]